Within NSCLC, ERBB3 expression is higher in adenocarcinoma compared with squamous (43) and other forms of lung cancer (44); and circulating ERBB3 mRNA levels correlate with higher TNM stage and poorer survival in adenocarcinoma (45). This evidence concerns the gene ERBB3 and adenocarcinoma.